No abstract available
MeSH terms
-
Bilirubin / blood
-
Chronic Disease
-
Evidence-Based Practice
-
Fluid Therapy / methods*
-
Hemodynamics*
-
Hepatorenal Syndrome* / classification
-
Hepatorenal Syndrome* / etiology
-
Hepatorenal Syndrome* / metabolism
-
Hepatorenal Syndrome* / physiopathology
-
Hepatorenal Syndrome* / therapy
-
Humans
-
Kidney / blood supply
-
Liver / blood supply
-
Liver Cirrhosis / complications*
-
Liver Cirrhosis / metabolism
-
Liver Cirrhosis / physiopathology
-
Liver Transplantation*
-
Lypressin / administration & dosage
-
Lypressin / adverse effects
-
Lypressin / analogs & derivatives*
-
Monitoring, Physiologic
-
Patient Selection
-
Portasystemic Shunt, Surgical*
-
Regional Blood Flow / drug effects
-
Renal Insufficiency* / diagnosis
-
Renal Insufficiency* / etiology
-
Renal Insufficiency* / metabolism
-
Renal Insufficiency* / physiopathology
-
Renal Insufficiency* / therapy
-
Serum Albumin / analysis
-
Serum Albumin / metabolism
-
Severity of Illness Index
-
Terlipressin
-
Vasoconstrictor Agents / administration & dosage
-
Vasoconstrictor Agents / adverse effects
Substances
-
Serum Albumin
-
Vasoconstrictor Agents
-
Lypressin
-
Terlipressin
-
Bilirubin